MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Galena Biopharma Company Profile (NASDAQ:GALE)

Consensus Ratings for Galena Biopharma (NASDAQ:GALE) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Buy Rating(s)
Consensus Rating:Buy (Score: 2.67)
Consensus Price Target: $5.17 (246.76% upside)

Analysts' Ratings History for Galena Biopharma (NASDAQ:GALE)
Show:
DateFirmActionRatingPrice TargetActions
8/7/2015MLV & Co.Reiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/7/2015Cantor FitzgeraldReiterated RatingSell$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/30/2015Roth CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2015Roth CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Maxim GroupReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/22/2015Roth CapitalReiterated RatingBuy$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/31/2015Maxim GroupReiterated RatingBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2015MLV & Co.Set Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2015Noble FinancialReiterated RatingBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Needham & Company LLCSet Price TargetBuy$7.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Cantor FitzgeraldSet Price TargetSell$2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2015MLV & Co.Set Price TargetBuy$5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/16/2015Maxim GroupSet Price TargetBuy$7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/20/2014MLV & Co.Boost Price TargetBuy$3.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2014Roth CapitalReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2014Cantor FitzgeraldReiterated RatingSell$2.25 -> $2.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/27/2014MLV & Co.Reiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/22/2014MLV & Co.Lower Price TargetBuy$5.00 -> $3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/21/2014Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/12/2014Needham & Company LLCLower Price TargetBuy$9.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2014Roth CapitalBoost Price Target$8.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014Noble FinancialReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2014MLV & Co.Lower Price Target$6.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2014Roth CapitalLower Price Target$12.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2014Cantor FitzgeraldDowngradeSell$3.50 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2014Cantor FitzgeraldDowngradeBuy -> Sell$3.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2014Noble FinancialBoost Price TargetBuy$4.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2014Maxim GroupBoost Price TargetBuy$9.00 -> $11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/21/2014Needham & Company LLCBoost Price Target$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/14/2014Roth CapitalBoost Price Target$11.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2014Maxim GroupBoost Price TargetBuy$6.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/26/2013OppenheimerInitiated CoverageOutperform$6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/27/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha